GTN - Transforming drug discovery through interdisciplinary innovation. Bringing a single new drug to the market costs $2.9bn and takes 15 years, with a high chance of failure and often delivering an intervention that barely differs from those already in the market. Projections into the future are not promising, with an expected 50% drop in R&D output every nine years. At GTN, a multidisciplinary, innovation-driven company, we are searching the astronomically large space of drug-like molecules with our unique patented technology, Generative Tensorial Networks. Our software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, discovering molecules entirely hidden from view. This will create substantial efficiencies in the whole drug development cycle.
GTN - Transforming drug discovery through interdisciplinary innovation. Bringing a single new drug to the market costs $2.9bn and takes 15 years, with a high chance of failure and often delivering an intervention that barely differs from those already in the market. Projections into the future are not promising, with an expected 50% drop in R&D output every nine years. At GTN, a multidisciplinary, innovation-driven company, we are searching the astronomically large space of drug-like molecules with our unique patented technology, Generative Tensorial Networks. Our software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, discovering molecules entirely hidden from view. This will create substantial efficiencies in the whole drug development cycle.
Company Information
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 11-50
- Revenue Range
- Not available
Location
- Address
- Block L, Tower Bridge Business Complex, Clements Rd, London SE16 4DG UK London
- City
- Region
- Postal Code
- SE16 4DG
- Country
